Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 18, 1994 - Issue 4-5
27
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Hb Fannin-Lubbock in Five Spanish Families is Characterized by two Mutations: β111 GTC->CTC (VAL->LEU) AND β119 GGC->GAC (GLY->ASP)

, , , , , & show all
Pages 297-306 | Received 17 Mar 1994, Accepted 30 Jun 1994, Published online: 07 Jul 2009
 

Abstract

We have sequenced the amplified β-globin genes of five, apparently unrelated, Spanish adults with a fast-moving hemoglobin variant, and observed a GGC->GAC mutation at codon 119 which identified the abnormality as Hb Fannin-Lubbock or α2β2119(GH2)Gly->Asp. In addition, we found a GTC->CTC change at codon 111 which leads to a Val->Leu replacement at this location. Protein analysis of the βA and βX chains from one of these individuals confirmed that both mutations are located on the same chromosome. It is hypothesized that some other known variants may carry an additional mutation in one of their exons, resulting in a silent amino acid substitution which may have an effect on some physicochemical property. In the case of Hb Fannin-Lubbock, it appears likely that the Val->Leu replacement at β111, rather than the Gly->Asp replacement of β119, is the cause of the instability of the variant. The Hb Fannin-Lubbock variant in these Spanish families had a normal oxygen affinity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.